3rd Annual Biologics Symposium - preclinical aspects of developing biologics
14-06-2019 09:00 - 16:00
H. Lundbeck A/S
2500 - Valby
The event is one of a series of free scientific symposia in Scandinavia organized by Envigo.
This event is focused on the preclinical aspects of developing biologics and is hosted by Lundbeck in Valby. A panel of industry experts will cover a wide range of topics related to preclinical aspects of biologics such as species selection, bioanalytical and toxicological aspects. It will be an educational and insightful day in Copenhagen with plenty of time for questions and networking with peers.
Space is limited so register today to secure your free place.
- ”Bringing bispecific antibodies from idea to patients.” - Per Norlén, MD. PhD, Assoc. Prof - CEO - Alligator BioScience
- ”Developing cell therapies.” - Dr. Alessandra De Riva - Principal Scientist - Envigo R&D
- ”Assessing reproductive toxicity when developing mAbs” - Qikun Zhuand - Senior Toxicologist - Lundbeck and David Meyers, Reproductive Toxicologist - Envigo
- ”TBC.” - Pekka Kallunki - Principal Scientist - Lundbeck
Contact Morten Fjordholt, Director – Pharmaceutical Development at Morten.firstname.lastname@example.org